STOCK TITAN

Pacira BioSciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022, at 3:00 PM ET. Interested parties can access the live audio via the company's website, with a replay available for two weeks post-event. Pacira is dedicated to providing non-opioid pain management solutions and has three commercial-stage products: EXPAREL®, ZILRETTA®, and ioveraº®. Their mission focuses on reducing reliance on opioids and developing innovative treatments for chronic pain and related conditions.

Positive
  • None.
Negative
  • None.

TAMPA, Fla., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 40th Annual J.P. Morgan Healthcare Conference at 3:00 PM ET on Monday, January 10, 2022. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

When will Pacira BioSciences present at the J.P. Morgan Healthcare Conference?

Pacira BioSciences will present on January 10, 2022, at 3:00 PM ET.

How can I access the live audio of Pacira's presentation?

The live audio can be accessed via the 'Events' page on Pacira's website.

What are the main products of Pacira BioSciences?

Pacira's main products include EXPAREL®, ZILRETTA®, and ioveraº®.

How long will the replay of Pacira's presentation be available?

The replay will be available for two weeks following the event.

What is the mission of Pacira BioSciences?

Pacira's mission is to provide non-opioid pain management solutions and reduce reliance on opioids.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

762.02M
46.13M
2.19%
109.51%
13.31%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA